Nephrocare Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11-08-2026 ,inter alia, to consider and approve the Unaudited Standalone ....

Ref: NEPHROPLUS/SE/065 July 24, 2026 To To BSE Limited National Stock Exchange of India Limited P.J. Towers, Dalal Street, 5th Floor, Exchange Plaza, Bandra (E), Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 544647 Scrip Symbol: NEPHROPLUS Through: BSE Listing Centre Through: NEAPS Subject: Intimation of Board Meeting Ref: Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015 (“SEBI Listing Regulations”) Dear Sir/ Madam, Pursuant to Regulation 29 and other applicable provisions of the SEBI Listing Regulations, please note that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, August 11, 2026, inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2026. In view of the above and further to our intimation dated June 19, 2026, the trading window for dealing in the securities of the Company has been closed for all the Designated Persons and their immediate relatives from June 22, 2026 till August 13, 2026 (both days inclusive). Yours sincerely, For Nephrocare Health Services Limited (Formerly Nephrocare Health Services Private Limited) Kishore Kathri Company Secretary & Head Legal ICSI M. No. F9895